OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
An inflammation resolution–promoting intervention prevents atrial fibrillation caused by left ventricular dysfunction
Roddy Hiram, Feng Xiong, Patrice Naud, et al.
Cardiovascular Research (2023) Vol. 120, Iss. 4, pp. 345-359
Closed Access | Times Cited: 12
Roddy Hiram, Feng Xiong, Patrice Naud, et al.
Cardiovascular Research (2023) Vol. 120, Iss. 4, pp. 345-359
Closed Access | Times Cited: 12
Showing 12 citing articles:
Specialized pro-resolving mediators in vascular inflammation and atherosclerotic cardiovascular disease
Gabrielle Fredman, Charles N. Serhan
Nature Reviews Cardiology (2024) Vol. 21, Iss. 11, pp. 808-823
Closed Access | Times Cited: 41
Gabrielle Fredman, Charles N. Serhan
Nature Reviews Cardiology (2024) Vol. 21, Iss. 11, pp. 808-823
Closed Access | Times Cited: 41
Atrial Cardiomyopathy Revisited - Evolution of a Concept. A Clinical Consensus Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Association (APHRS), and the Latin American Heart Rhythm Society (LAHRS)
Andreas Goette, Domenico Corradi, Dobromir Dobrev, et al.
EP Europace (2024) Vol. 26, Iss. 9
Open Access | Times Cited: 41
Andreas Goette, Domenico Corradi, Dobromir Dobrev, et al.
EP Europace (2024) Vol. 26, Iss. 9
Open Access | Times Cited: 41
TherapeuticSpp1silencing in TREM2+cardiac macrophages suppresses atrial fibrillation
Noor Momin, Steffen Pabel, Arnab Rudra, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Noor Momin, Steffen Pabel, Arnab Rudra, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
A short history of the atrial NLRP3 inflammasome and its distinct role in atrial fibrillation
Theresa Poppenborg, Arnela Saljic, Florian Bruns, et al.
Journal of Molecular and Cellular Cardiology (2025) Vol. 202, pp. 13-23
Open Access
Theresa Poppenborg, Arnela Saljic, Florian Bruns, et al.
Journal of Molecular and Cellular Cardiology (2025) Vol. 202, pp. 13-23
Open Access
RvD1 and LXA4 inhibitory effects on cardiac voltage-gated potassium channels
Alicia de la Cruz, Carlotta Ronchi, Chiara Bartolucci, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 187, pp. 118083-118083
Closed Access
Alicia de la Cruz, Carlotta Ronchi, Chiara Bartolucci, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 187, pp. 118083-118083
Closed Access
17(R)-Resolvin D1: a novel approach for SCD cardiomyopathy
Thilina U. Jayawardena, Gavin Y. Oudit
Blood (2025) Vol. 145, Iss. 17, pp. 1835-1837
Closed Access
Thilina U. Jayawardena, Gavin Y. Oudit
Blood (2025) Vol. 145, Iss. 17, pp. 1835-1837
Closed Access
Atrial cardiomyocytes contribute to the inflammatory status associated with atrial fibrillation in right heart disease
Ewen Le Quilliec, Charles-Alexandre LeBlanc, Orlane Neuilly, et al.
EP Europace (2024) Vol. 26, Iss. 4
Open Access | Times Cited: 3
Ewen Le Quilliec, Charles-Alexandre LeBlanc, Orlane Neuilly, et al.
EP Europace (2024) Vol. 26, Iss. 4
Open Access | Times Cited: 3
Factors predicting the recurrence of atrial fibrillation after catheter ablation: A review
De-Gang Mo, Mengmeng Wang, Peng Zhang, et al.
Heliyon (2024) Vol. 10, Iss. 13, pp. e34205-e34205
Open Access | Times Cited: 3
De-Gang Mo, Mengmeng Wang, Peng Zhang, et al.
Heliyon (2024) Vol. 10, Iss. 13, pp. e34205-e34205
Open Access | Times Cited: 3
A new year’s resolution to resolve atrial fibrillation: Resolvin D1 emerges as a powerful target against post-MI atrial remodelling
Juan Velasco, Fadi G. Akar
Cardiovascular Research (2024) Vol. 120, Iss. 4, pp. 329-330
Open Access | Times Cited: 2
Juan Velasco, Fadi G. Akar
Cardiovascular Research (2024) Vol. 120, Iss. 4, pp. 329-330
Open Access | Times Cited: 2
Colchicine for the prevention of atrial fibrillation: Why do some studies say ‘yes’, and others say ‘no’?
Abir Attia, Roddy Hiram
International Journal of Cardiology (2024) Vol. 408, pp. 132110-132110
Closed Access | Times Cited: 2
Abir Attia, Roddy Hiram
International Journal of Cardiology (2024) Vol. 408, pp. 132110-132110
Closed Access | Times Cited: 2
Daily Exposure to Chlordecone, an Organochlorine Pesticide, Increases Cardiac Fibrosis and Atrial Fibrillation Vulnerability
Alexia Fundere, Andrew Rose, Feng Xiong, et al.
Journal of Hazardous Materials (2024) Vol. 478, pp. 135533-135533
Open Access | Times Cited: 1
Alexia Fundere, Andrew Rose, Feng Xiong, et al.
Journal of Hazardous Materials (2024) Vol. 478, pp. 135533-135533
Open Access | Times Cited: 1
RvD1 and LXA4 inhibitory effects on cardiac voltage-gated potassium channels
Alicia de la Cruz, Carlotta Ronchi, Chiara Bartolucci, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Alicia de la Cruz, Carlotta Ronchi, Chiara Bartolucci, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
A Short History of the Atrial Nlrp3 Inflammasome and its Distinct Role in Atrial Fibrillation
Theresa Poppenborg, Arnela Saljic, Florian Bruns, et al.
(2024)
Closed Access
Theresa Poppenborg, Arnela Saljic, Florian Bruns, et al.
(2024)
Closed Access
ANXA1-FPR2 axis mitigates the susceptibility to atrial fibrillation in obesity via rescuing AMPK activity in response to lipid overload
Peng Liu, Lu Wang, Yixin Wang, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access
Peng Liu, Lu Wang, Yixin Wang, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access
